Monitoring combines objective tests and patient reports
TB-500, a synthetic fragment corresponding to the active region of the endogenous peptide Thymosin Beta-4, drives the cellular migration phase of repair by sequestering G-actin, promoting cell motility, and mobilising stem and progenitor cells to sites of tissue disruption
Current Pharmaceutical Design, 16(10), 1224-1234
Here's what you need to know: AOD 9604 is real, it works, but it's not magic
TB-500 operates through actin regulation, cellular migration enhancement, and anti-inflammatory cytokine modulation
A 16-year-old on treatment would need monthly check-ins with their prescribing physician, quarterly labs, and ongoing behavioral support to maximize safety and effectiveness